Terazosin |
Hytrin |
Terazosin Systematic (IUPAC) name [4-(4-amino-6,7-dimethoxy-quinazolin-2-yl) piperazin-1-yl]- tetrahydrofuran-2-yl-methanone Identifiers CAS number 63590-64-7 ATC code G04CA03 PubChem 5401 DrugBank APRD00667 Chemical data Formula C19H25N5O4 Mol. weight 387.433 g/mol Pharmacokinetic data Bioavailability ? Protein binding 90-94% Metabolism ? Half life 12 hours Excretion ? Therapeutic considerations Pregnancy cat. ? Legal status ...
Wikipedia - [full article]
Terazosin Clinical Trials
- Excessive Sweating Caused by Antidepressants: Measurement and Treatment With Terazosin
ClinicalTrials.gov Identifier: NCT00449683 - Recruiting
Hyperhidrosis
- Pilot Study of Terazosin in Treatment of Antidepressant Induced Excessive Sweating
ClinicalTrials.gov Identifier: NCT00237510 - Recruiting
Antidepressant Induced Excessive Sweating
- Randomized Trial Comparing Terazosin 5 mg Daily and Doxazosin GITS 4 mg Daily for Trial Without Catheter in Acute Urinary Retention With Long Term Follow up
ClinicalTrials.gov Identifier: NCT00563485 - Terminated
Prostatic Hyperplasia; Urinary Retention

Not Signed In -

